Christopher Galloway
Keine laufenden Positionen mehr
Profil
Christopher D.
Galloway worked as a Medical Affairs Director at Merck & Co., Inc. from 2016 to 2018, followed by a position as Senior Medical Director-Medical Affairs at La Jolla Pharmaceutical Co. from 2018 to 2020.
He also worked as a Medical Director at DaVita Clinical Research and as a Medical Director-Global Clinical Development at Rakuten Medical, Inc. from 2016 to 2018.
Currently, he is the Chief Medical Officer at Diffusion Pharmaceuticals, Inc. Dr. Galloway received his undergraduate degree from The University of Texas at Austin and his doctorate from the University of Texas Medical Branch.
Ehemalige bekannte Positionen von Christopher Galloway
| Unternehmen | Position | Ende |
|---|---|---|
| DIFFUSION PHARMA | Chief Tech/Sci/R&D Officer | 01.03.2023 |
| LA JOLLA PHARMACEUTICAL COMPANY | Chief Tech/Sci/R&D Officer | 01.09.2020 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 01.07.2018 |
Rakuten Medical, Inc.
 Rakuten Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Rakuten Medical, Inc. operates as a clinical stage biotechnology company which develops tumor-targeted precision therapies. It develops new anticancer therapies based on the photoimmunotherapy platform. The company was founded in 2010 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01.01.2018 |
DaVita Clinical Research
 DaVita Clinical Research Medical/Nursing ServicesHealth Services Part of DaVita, Inc., DaVita Clinical Research is a research arm of DaVita that specializes in retrospective research to improve clinical outcomes. The American company assists pharmaceutical and medical device companies in designing, recruiting, and completing clinical trials using its renal research site network. The private company's unique approach is based on a provider-based renal research site network. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Christopher Galloway
| The University of Texas at Austin | Undergraduate Degree |
| University of Texas Medical Branch | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
DaVita Clinical Research
DaVita Clinical Research Medical/Nursing ServicesHealth Services Part of DaVita, Inc., DaVita Clinical Research is a research arm of DaVita that specializes in retrospective research to improve clinical outcomes. The American company assists pharmaceutical and medical device companies in designing, recruiting, and completing clinical trials using its renal research site network. The private company's unique approach is based on a provider-based renal research site network. | Health Services |
Diffusion Pharmaceuticals, Inc.
 Diffusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA. | Health Technology |
Rakuten Medical, Inc.
Rakuten Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Rakuten Medical, Inc. operates as a clinical stage biotechnology company which develops tumor-targeted precision therapies. It develops new anticancer therapies based on the photoimmunotherapy platform. The company was founded in 2010 and is headquartered in San Diego, CA. | Commercial Services |
